MODERNA, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102.6 USD | -0.81% |
|
-4.13% | +3.16% |
| Apr. 16 | Moderna Insider Sold Shares Worth $1,575,300, According to a Recent SEC Filing | MT |
| Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |  |
Chart calendar Moderna, Inc.
24d559069e1d5894f4f63.dDPf1ep9LzfYw3Cjy-3vpf5DylU1SaILueMwqujUCqc.LQuomIsVXgO7qQrGk4WunLsikANscMhq36Vo8NC5QcEHcLSsrjsCf6C7RA~633740effe27d01907b80a7d19088ef4
Upcoming events on Moderna, Inc.
Past events on Moderna, Inc.
| 2024-03-27 08:50 am | Investor Meeting - Vaccines Day |
| 2024-03-12 02:35 pm | Barclays Global Healthcare Conference |
| 2024-03-06 01:30 pm | TD Cowen Health Care Conference |
| 2024-02-22 08:00 am | Q4 2023 Earnings Call |
| 2024-02-22 06:30 am | Q4 2023 Earnings Release |
| 2024-01-08 06:45 pm | JPMorgan Healthcare Conference |
| 2023-12-07 08:00 am | Investor Day - ESG |
| 2023-11-30 12:30 pm | Piper Sandler Healthcare Conference |
| 2023-11-16 03:30 am | Jefferies London Healthcare Conference |
| 2023-11-09 08:00 am | UBS Global Biopharma Conference |
| 2023-11-08 08:00 am | Investor Day - AI Day |
| 2023-11-02 08:00 am | Q3 2023 Earnings Call |
| 2023-11-02 06:30 am | Q3 2023 Earnings Release |
| 2023-09-13 01:00 pm | R&D Day |
| 2023-09-12 12:15 pm | Morgan Stanley Global Healthcare Conference |
| 2023-08-03 08:00 am | Q2 2023 Earnings Call |
| 2023-08-03 06:30 am | Q2 2023 Earnings Release |
| 2023-06-14 07:40 pm | Goldman Sachs Global Healthcare Conference |
| 2023-06-08 10:30 am | Jefferies Healthcare Conference |
| 2023-06-05 07:00 pm | American Society of Clinical Oncology Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 60,2 63,6 -5.26% | 803 502 60.19% | 18 471 17 940 2.96% | 19 263 19 134 0.67% | 6 848 6 514 5.13% | 4 212 |
|
EBITDA Million USD | Released Forecast Spread | -515 -536 3.99% | -732 -507 -44.48% | 13 528 12 626 7.14% | 9 768 10 056 -2.86% | -3 618 -4 681 22.71% | -2 826 |
|
EBIT Million USD | Released Forecast Spread | -546 -537 -1.57% | -763 -582 -31.05% | 13 296 12 562 5.84% | 9 420 9 956 -5.38% | -4 239 -4 868 12.91% | -3 071 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -515 -533 3.37% | -745 -575 -29.43% | 13 285 12 585 5.56% | 9 575 10 119 -5.37% | -3 942 -4 505 12.49% | -2 774 |
|
Net income Million USD | Released Forecast Spread | -514 -517 0.63% | -747 -582 -28.42% | 12 202 11 445 6.62% | 8 362 8 739 -4.31% | -4 714 -5 283 10.77% | -2 808 |
|
EPS USD | Released Forecast Spread | -1,55 -1,56 0.79% | -1,96 -1,25 -56.83% | 28,3 26,9 5.17% | 20,1 21,3 -5.53% | -12,3 -13,5 8.92% | -7,25 |
| Announcement Date | 26/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7 211 6 735 7.07% | 6 066 4 426 37.06% | 4 749 3 955 20.09% | 3 364 3 527 -4.61% | 5 084 5 019 1.29% | 1 862 1 120 66.24% | 344 306 12.58% | 1 831 1 382 32.49% | 2 811 2 533 11% | 131 | 72,2 | 1 584 | 2 428 | 633 |
|
EBITDA Million USD | Released Forecast Spread | 5 488 4 948 10.91% | 208 -1 081 119.24% | ||||||||||||
|
EBIT Million USD | Released Forecast Spread | 5 410 4 727 14.44% | 4 227 2 790 51.5% | 2 447 2 175 12.5% | 1 166 1 518 -23.17% | 1 580 2 149 -26.47% | -366 -658 44.42% | -1 867 -1 684 -10.88% | -2 012 -852 -136.15% | 6,00 -512 101.17% | -1 412 | -1 393 | -375 | 169 | -977 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 5 410 4 629 16.88% | 4 229 2 829 49.48% | 2 474 2 115 16.96% | 1 217 1 596 -23.74% | 1 655 2 199 -24.74% | -305 -572 46.72% | -1 749 -1 606 -8.9% | -1 958 -735 -166.48% | 70,0 -451 115.52% | -1 338 | -1 340 | -315 | 213 | -819 |
|
Net income Million USD | Released Forecast Spread | 4 868 4 145 17.43% | 3 657 2 419 51.15% | 2 197 1 801 22.02% | 1 043 1 320 -21% | 1 465 1 884 -22.24% | 79,0 -662 111.93% | -1 380 -1 587 13.06% | -3 630 -754 -381.44% | 217 -347 162.57% | -1 370 | -1 371 | -363 | 275 | -819 |
|
EPS USD | Released Forecast Spread | 11,3 9,61 17.53% | 8,58 5,63 52.44% | 5,24 4,50 16.34% | 2,53 3,19 -20.57% | 3,61 4,75 -23.99% | 0,19 -1,74 110.9% | -3,62 -4,10 11.66% | -9,53 -1,98 -381.38% | 0,55 -0,98 156.29% | -3,57 | -3,53 | -0,88 | 0,60 | -2,56 |
| Announcement Date | 24/02/22 | 04/05/22 | 03/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 03/08/23 | 02/11/23 | 22/02/24 | - | - | - | - | - |
More events
Past sector events for Moderna, Inc.
| Today | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MRNA Stock
- Calendar Moderna, Inc.
